Science Explorer Back to mapMap
Discussion
Researcher · Université Laval · Canada

Marc Germain

Marc Germain publishes mostly in Molecular Biology, Epidemiology and Oncology, on topics such as Autophagy in Disease and Therapy, Cell death mechanisms and regulation and PARP inhibition in cancer therapy.

ORCID 0000-0001-7942-3185 OpenAlex
World rank
#1,808,006
of 7,710,434 ranked researchers
Rank in Canada
#60,218
of 183,316
Works
16
Citations
8.1k
Citations per work
506.1
h-index
12
i10-index 12Top 65% in Molecular Biology
Marc Germain

What does Marc Germain research?

Marc Germain's work is mostly in Biochemistry, Genetics and Molecular Biology (33%), Medicine (33%), Agricultural and Biological Sciences (7%).

Life Sciences: 6 works · 40.5% of their workBiochemistry, Genetics and Molecular Biology: 5 works · 33.4% of their workMolecular Biology: 5 works · 28.6% of their workCell Biology: 1 works · 4.8% of their workAgricultural and Biological Sciences: 1 works · 7.1% of their workPlant Science: 1 works · 7.1% of their workHealth Sciences: 5 works · 33.3% of their workMedicine: 5 works · 33.3% of their workEpidemiology: 3 works · 19.0% of their workOncology: 2 works · 9.5% of their workImmunology and Allergy: 1 works · 4.8% of their workEverything else: 4 works · 26.2% of their workTHEIR WORKMarc Germain16works
Life Sciences40%Health Sciences33%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology533.4%
    2. Agricultural and Biological Sciences17.1%
    1. Medicine533.3%
  3. Everything else426.2%
  1. 1Molecular Biology29% of their works
  2. 2Epidemiology19% of their works
  3. 3Oncology10% of their works
  4. 4Plant Science7% of their works
  5. 5Cell Biology5% of their works
  6. 6Immunology and Allergy5% of their works

Research topics

Which keywords describe Marc Germain's research?

The keywords of their largest research topics: Apoptosis, Cell Death, Cancer, Inflammation, Cancer Therapy, Autophagy, Disease and Bcl-2 Family.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Apoptosis153 topics
  2. Cell Death113 topics
  3. Cancer102 topics
  4. Inflammation102 topics
  5. Cancer Therapy92 topics
  6. Autophagy81 topic
  7. Disease81 topic
  8. Bcl-2 Family51 topic
  9. Mitochondria51 topic
  10. BRCA Mutation41 topic
  11. PARP Inhibitors41 topic
  12. RNA Interference31 topic
  13. siRNA Delivery31 topic
  14. Cell Adhesion21 topic
  15. Endoplasmic Reticulum21 topic
  16. Flooding Stress21 topic
  17. Integrins21 topic
  18. Stress21 topic
  19. Submergence Tolerance21 topic
  20. Cassava11 topic
  21. Cyanogenic Glycosides11 topic

Where does Marc Germain work?

Marc Germain's main affiliation in the publication record is Université Laval, Canada.

How many publications and citations does Marc Germain have?

OpenAlex counts 16 works and 8,097 citations for Marc Germain, an h-index of 12, ranking #1,808,006 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Marc Germain

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Marc Germain. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.